ArticleFrontiers in oncology2025

Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.

Anne E G Lenferink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.